PharmaBoardroom

Orphan Drugs & Rare Diseases: China

An intro to the legal situation for orphan drugs and rare diseases in China. Prepared in association with Fangda Partners, one of China’s most…

Cannabinoid Drugs, Medicinal Cannabis & Opioid Drugs: China

Cannabinoid drugs, medicinal cannabis & opioid drugs in India - a comprehensive legal overview. Prepared in association with Fangda Partners, one…

Regulatory Reforms: China

The key facts about regulatory reforms in Chinese pharma. Prepared in association with Fangda Partners, one of China’s most prestigious and…

Patents & Trademarks: China

An outline of the legal situation around patents and trademarks for pharmaceuticals in China. Prepared in association with Fangda Partners, one of…

Product Liability: China

A comprehensive guide to the legal implications around product liability in China. Prepared in association with Fangda Partners, one of China’s…

Traditional Medicines and OTC Products: China

A legal intro to traditional medicines and OTC products in China. Prepared in association with Fangda Partners, one of China’s most prestigious and…

Marketing, Manufacturing, Packaging & Labeling, Advertising:…

A brief overview of the situation regarding marketing, manufacturing, packaging & labeling and advertising within Chinese pharma. Prepared in…

Preclinical and Clinical Trial Requirements: China

The essential requirements for conducting preclinical and clinical trials in China. Prepared in association with Fangda Partners, one of China’s…

Regulatory, Pricing and Reimbursement: China

An intro to the regulatory, pricing and reimbursement scenario for pharmaceuticals in China. Prepared in association with Fangda Partners, one of…

China Pharma News: Fosun Sales up 20%; MNC Price Manoeuvres Lead…

The latest news from Chinese pharma, including Fosun Pharma’s 2021 interim results; how AstraZeneca, Bayer, Eli Lilly, Merck & Co., Novartis,…

Denmark: Data Crucial To Innovative Access Agreements

Established in 2017, the Danish Medicines Council is the health technology assessment (HTA)-like body in Denmark which assesses the value for patients…

Turkey: A Pharma Talent Hotbed

Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has compiled a strategic overview of…

Tagged with